Citations

Clear

705 citation(s) found for "Cooper, C B".

Neuroimmunology of Epilepsy: Mechanisms, Treatments, and Clinical Insights
Goldman, Alica M. , Wong, Nora , Vezzani, Annamaria , Eschbach, Krista, Husari, Khalil, Feyissa, Anteneh M. , Gofton, Teneille, Valencia, Ignacio , Feyissa, A M , Valencia, Ignacio , Vezzani, Annamaria , Goldman, Alica M , Dubey, Divyanshu , Gofton, Teneille

Mayo Clinic

Epilepsy Currents | July 6, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15357597261464381 | PMID 42416145 Get It

Immune-mediated epilepsies represent an etiologically unique category defined by immune activation within the central nervous system that initiates a pathophysiological cascade resulting in seizures, encephalopathy, and sometimes epileptogenesis with long-term epilepsy. Once considered rare and largely confined to paraneoplastic or postinfectious syndromes, immune-mediated and inflammatory mechanisms are now recognized across a broad spectrum ranging from acute autoimmune encephalitis with reversible seizures, new-onset refractory status epilepticus, or febrile illness-related refractory status epilepticus, to chronic autoimmune-associated epilepsy and drug-refractory structural epilepsies. This review integrates historical perspectives, mechanistic insights from animal and human studies, and contemporary clinical frameworks. It synthesizes advances in neuroimmunology, clinical phenotyping, diagnostics, immunomodulatory and antiseizure therapies, neuromodulation, and patient and family centered outcomes, and outlines future directions focused on biomarker-driven precision medicine, disease-modifying strategies, and interdisciplinary care models.
Targeting Cellular Pseudo-Senescence to Overcome PARP inhibitors Resistance in BRCA1 -Mutated Breast Cancer
Chatla, Srinivas , Indulkar, Shreya, Kim, Dongwook, Wei, Xiaoyu, Liao, Yun , Yang, Dan, Pompetti, Anthony , Calendo, Gennaro , Edmonston, Tina, Wang, L, Huang, Jian , Chatla, Srinivas , Tian, Zhen , Wang, Congli , Edmonston, Tina Bocker , Lou, Zhenkun , Skórski, Tomasz

Mayo Clinic

No container title available | June 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.06.25.734617 Get It

Abstract Poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi) are a mainstay therapy for homologous recombination (HR)-deficient cancers; however, resistance remains a major clinical challenge. Previously, through a genome wide CRISPR screen, we identified ZNF251 haploinsufficiency as a novel driver of PARPi resistance. In BRCA1 -mutant ( BRCA1 mut ) cells, ZNF251 deficiency led to HR hyperactivation, conferring PARPi resistance that could be reversed by RAD51 inhibition. In this study, we further show that ZNF251 deficiency induces replication stress and a pseudo-senescence state, in which cells exhibit molecular and phenotypic markers of senescence while retaining proliferative capacity. Because senomorphic and senolytic therapies can target senescent cells, we tested whether these approaches could overcome PARPi resistance in ZNF251 -deficient breast cancer cells. Critically, targeting this senescence-like state with either senomorphic agents, such as cytokine inhibitors, or senolytic agents, such as BCL-2 and BCL-XL inhibitors, overcame PARPi resistance ex vivo and in vivo . Importantly, pseudo-senescence was also observed in other PARPi-resistant contexts driven by HR hyperactivation, including 53BP1 - and Shieldin -mutant cells, suggesting that it may represent a broader mechanism underlying PARPi resistance in breast cancer. Furthermore, in two olaparib-resistant, BRCA -mutant triple-negative breast cancer organoid models, treatment with DT2216, a BCL-XL–targeting PROTAC, sensitized both models to olaparib. Together, our work defines a novel pathway linking HR hyperactivation, replication stress, and pseudo-senescence, and positions both senomorphic and senolytic therapies as promising strategies to overcome PARPi resistance in BRCA1 mut breast cancer. Highlights ZNF251 deficiency drives PARP inhibitor resistance through HR hyperactivation, replication stress, and pseudo-senescence in BRCA1 -mutant breast cancer. Senomorphic and senolytic therapies overcome PARP inhibitor resistance in vitro , in vivo , and in patient-derived organoid models. Pseudo-senescence represents a shared vulnerability of HR-hyperactivated PARPi-resistant cancers and can be therapeutically targeted.
Proprioceptive Stimuli as a Trigger for Leucine-Rich Glioma-Inactivated-1 (LGI1) IgG Associated Autoimmune Seizures, a Case Report
Gupta, Ashutosh , Holmes, Miles D., Dubey, Divyanshu, Omidi, Shirin Jamal, Goyal, Megan, Sriwastava, Shitiz, Gupta, Rajesh , Gupta, Ashutosh , Gupta, Rajesh Kumar , Dubey, Divyanshu , Goyal, Megan, Sriwastava, Shitiz

Mayo Clinic

The Neurohospitalist | June 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/19418744261463745 | PMID 42368480 Get It

Leucine-rich glioma-inactivated-1 (LGI1) IgG-associated autoimmune encephalitis typically presents with faciobrachial dystonic seizures, hyponatremia, and temporal lobe MRI abnormalities. However, the clinical spectrum of LGI1 IgG-associated AE extends beyond these classical features, with reports of diverse seizure semiologies and atypical presentations challenging traditional diagnostic paradigms. This study reports a male in his late 60s presenting with recurrent episodes of right foot cramping and electric shock-like pain, progressing to generalized tonic-clonic seizures. Initial workup suggested chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), but LGI1 IgG antibodies were subsequently detected. Despite treatment with intravenous immunoglobulin (IVIG), the seizures persisted. This case highlights the heterogeneity in LGI1 encephalitis presentations. The patient’s proprioceptive-induced reflex seizures represent a rare manifestation of the disease. Treatment with rituximab, a B-cell depleting therapy, resulted in significant improvement, suggesting its potential effectiveness in LGI1 encephalitis with a resistant seizure course. The case also emphasizes the intricate interplay between the mesial temporal lobe, basal ganglia, and frontal regions in LGI1 encephalitis pathophysiology.
Myocardial Perfusion and Fluorodeoxyglucose Uptake Patterns in Cardiac Sarcoidosis Stratified by Diagnostic Category and Systemic Involvement
Davison, Jen, Elwazir, Mohamed, AbouEzzeddine, Omar, Bois, John, Giudicessi, John, Chareonthaitawee, Panithaya, Cooper, Leslie, Rosenbaum, A., Davison, Jenna , Davison, Jenna M , Sykora, Daniel , Tersalvi, Gregorio , Elwazir, Mohamed Y. , AbouEzzeddine, Omar F. , Bois, John P. , Giudicessi, John R. , Chareonthaitawee, Panithaya

Mayo Clinic

Circulation Journal | June 25, 2026 | Volume: 90 | Issue: 11 | Pages: 1745-1747

10.1253/circj.cj-26-0423 | PMID 42366066 Get It

Understanding Anesthesiologists’ Adoption of Evidence-based Neuromuscular Monitoring and Reversal Best Practices
Weinger, Matthew B., Andreae, Michael, Anders, Shilo, Slagle, Jason , Reale, Carrie , Faiman, Janelle, Torsher, Laurence, Shotwell, Matthew S., Gaba, David M. , Burden, Amanda, Andreae, Michael H. , Andreae, Michael H , Weinger, Matthew B. , Anders, Shilo , DeClercq, Josh , Banerjee, Arna , Torsher, Laurence C., Shotwell, Matthew S. , Burden, Amanda R.

Mayo Clinic

Anesthesiology Open | June 23, 2026 | Volume: 1 | Issue: 2 | Pages: e0020

10.1097/ao9.0000000000000020 Get It

Anesthesiologists are sometimes slow to adopt new technologies despite proven benefits. The authors undertook to understand community anesthesiologists’ perspectives and practices regarding neuromuscular monitoring and reversal. Specifically, they sought to generate evidence for why some guidance-congruent practices— i.e. , quantitative train-of-four monitoring, ulnar nerve stimulation, and evidence-based reversal—remain inconsistently adopted despite robust evidence of patient harm from residual neuromuscular blockade and decades of effort to improve adoption. Thirty-six U.S. community anesthesiologists underwent a detailed qualitative cognitive interview. Analysis revealed four clinician archetypes whose neuromuscular monitoring and reversal practices are shaped by identifiable individual and practice-related biases and device- and system-level barriers. Perceived confidence in sugammadex efficacy was frequently cited as a rationale for omitting quantitative neuromuscular monitoring. The authors propose a research and implementation action agenda to close the evidence-to-practice gap in neuromuscular monitoring and reversal.
Correlation of Serotonin Release Assay Positivity With  ELISA OD Value and Impact on the Management of Patients Suspected With HIT
Ianosi‐Irimie, Monica, Aljuboori, Omar , Edmonston, Tina Bocker, Worfolk, Laura A., Bi, Caixia , Tong, Carmen , Noh, Lina J., Espinoza, Andrew, Sahud, Mervyn A. , Dlott, Jeffrey S., Racke, Frederick K., Wong, Edward C.C. , Ianosi-Irimie, Monica, Edmonston, Tina Bocker , Racke, Frederick Karl

Mayo Clinic

International Journal of Laboratory Hematology | June 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/ijlh.70176 | PMID 42316906 Get It

Women’s musculoskeletal health: insights from the 2024 National Academies of Sciences, Engineering, and Medicine report on chronic conditions
Matthews, M, Cooper, R, Dallas, S L, Khosla, Sundeep , Lengyel, K, Nizar, N, South, S M, Meulen, M C H van der, Alliston, T, Bouxsein, Mary , Wysolmerski, John J. , Dallas, Sarah L , Bouxsein, Mary L , Khosla, Sundeep , South, Sanique M. , Meulen, Marjolein C. H. van der , Alliston, Tamara N.

Mayo Clinic

Journal of Bone and Mineral Research | June 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/jbmr/zjag092 | PMID 42315116 Get It

Abstract In 2024, the National Academies of Sciences, Engineering, and Medicine (NASEM) published a report entitled Advancing Research on Chronic Conditions in Women. A major purpose of this report was to summarize the current state of research into a series of 21 chronic conditions that affect women differently or that are more common in women. The American Society for Bone and Mineral Research (ASBMR) established a working group to evaluate the NASEM report’s implications for women’s musculoskeletal (MSK) health. This perspective summarizes key research gaps identified in the NASEM report, including the lack of sex-specific data, underrepresentation of women in clinical studies, and minimal integration of MSK health with other chronic conditions. The NASEM report underscores the need for more comprehensive study designs that consider hormonal, genetic, and social determinants of health across the lifespan. In addition to osteoporosis, in this perspective, the ASBMR working group highlights emerging but poorly understood evidence of detrimental effects on musculoskeletal biology in non-MSK, chronic diseases that were identified in the NASEM report to disproportionately affect women. To advance the field, we advocate for better diagnostics, increased investment, and stronger representation of women in research studies. Addressing these gaps is critical for improving prevention, care, and outcomes for chronic conditions that uniquely or disproportionately affect women.
IL15-mediated crosstalk between LSECs and CD8⁺ tissue-resident memory T cells drives alcohol-associated hepatitis
Zhong, Weizhe , Ricci-Azevedo, Rafael , Wang, Shaohua , Cooper, Shawna A. , Ma, Jing , Xhafi, Fiona, Zhao, Dejian , Gao, H, Shah, Vijay H. , Liangpunsakul, Suthat , Ouyang, Xinshou , Cao, Sheng , Sun, Zhaoli, Iwakiri, Yasuko , Liu, Mengfei , Zhao, Dejian , Gao, Hui , Liangpunsakul, Suthat , Ouyang, Xinshou , Mehal, Wajahat Z , Cao, Sheng , Peiffer, Brandon , Iwakiri, Yasuko , Vassallo, Robert , Liu, Mengfei , Cooper, Shawna A , Ma, Jing , Swartzwelter, Benjamin J. , Xhafi, F., Sun, Zhaoli , Peiffer, Brandon , Vassallo, Robert

Mayo Clinic

Hepatology Communications | June 11, 2026 | Volume: 10 | Issue: 7 | Pages: No page available

10.1097/hc9.0000000000000967 | PMID 42275578 Get It

Background: Alcohol-associated hepatitis (AH) is a severe inflammatory liver condition driven by dysregulated immune responses. CD8 T cells accumulate in the liver during AH, yet their functional role remains poorly defined. Methods: A murine NIAAA chronic-binge model with lipopolysaccharide (LPS) challenge was used. Single-cell RNA sequencing of liver and blood immune cells defined CD8 T cell subsets, followed by pathway analysis and reanalysis of human AH datasets. Spatial relationships were validated by immunohistochemistry of human AH liver tissue with CD8 T RM and liver sinusoidal endothelial cell (LSEC) co-staining. LSEC–CD8 T cell interactions were examined using in vitro co-culture, and signaling pathways were assessed by bulk RNA sequencing and phospho-protein analyses. IL15 function was evaluated by in vivo neutralization. Results: Single-cell RNA sequencing in the murine AH model revealed a distinct population of CD8 tissue-resident memory T cells (T RM ) with heightened activation and proinflammatory cytokine production. Analysis of human AH liver single-cell RNA sequencing data, along with immunohistochemistry validation, supported CD8 T RM enrichment in diseased tissue. IL15 emerged as a prominent pathway linked to T RM activation, and IL15 blockade reduced T RM abundance and attenuated EtOH/ lipopolysaccharide-induced liver injury. Mechanistically, LSECs not only provided a structural niche for T RM retention but also amplified IL15 signalling. In vitro, coculture experiments demonstrated that LSECs intensified activation in pre-stimulated CD8 T cells in a stimulus-dependent manner: under IL15 stimulation, LSECs boosted effector function without inducing cell death, whereas under T-cell receptor stimulation, LSECs drove hyperactivation and activation-induced cell death. Bulk RNA-seq and phospho-protein analysis identified the PI3K-AKT pathway as a shared pathway enhanced by LSEC coculture in activated CD8 T cells. These findings define a context-dependent mechanism in which LSECs promote IL15-driven signaling through AKT pathway amplification, promoting T RM persistence and inflammatory activity in AH. Conclusions: IL15-associated signaling within the hepatic microenvironment, shaped by LSEC-CD8 T-cell interactions, promotes activation and persistence of CD8 T RM cells in AH. Targeting the IL15-LSEC-AKT axis may disrupt pathogenic T RM niches and represent a promising therapeutic strategy for severe AH.
Graph Neural Networks for Medical Imaging Analysis and Biological Data: Integrating Topology, Geometry, Radiomics, and Generative AI
Singh, Yashbir , Himeur, Yassine , Farrelly, Colleen M., Kadzue, Peguy Kem-Meka Tiotsop , Rozenblit, Jennifer Z. , Kunovac, Amina , Pappas, Isabelle C., Choudhary, Ashok , Salehi, Sara , Atalla, Shadi , Hathaway, Quincy A. , Singh, Yashbir , Hathaway, Quincy A , Salehi, Sara , Rozenblit, Jennifer , Farrelly, Colleen , Choudhary, Ashok

Mayo Clinic

Bioengineering | June 3, 2026 | Volume: 13 | Issue: 6 | Pages: 638

10.3390/bioengineering13060638 | PMID 42351883 Get It

Graph neural networks (GNNs) are increasingly used for medical imaging analysis and biological data modeling, where the integration of radiomics, topology, geometry, and generative artificial intelligence (AI) may improve representation learning from medical images and related biomedical data. Across the reviewed literature, GNNs show particular value for modeling spatial relationships, multimodal interactions, graph-structured biological networks, and non-Euclidean imaging features that are difficult to capture using conventional convolutional architectures alone. Topology- and geometry-aware approaches further expand this capability by encoding multi-scale structure, higher-order relationships, curvature, geodesic organization, and equivariant spatial priors. Hybrid graph–transformer models and generative graph methods represent emerging directions for modeling long-range dependencies, augmenting scarce datasets, supporting synthetic pretraining, and improving representation learning in low-label or heterogeneous biomedical settings. However, clinical translation remains limited by variability in graph construction, limited external validation, computational cost, scalability constraints, interpretability challenges, and uncertainty regarding the biological realism of synthetic data. Overall, this review highlights that GNN-based medical imaging analysis is most likely to advance when graph construction is biologically justified, model performance is evaluated across diverse clinical cohorts, and technical gains are paired with transparent validation, interpretability, and implementation strategies.
A 10-Year Comprehensive, Single-Center, Retrospective Analysis on Juxtapleural Nodules: Insights into Classification and Risk
Pappas, Isabelle C., Hathaway, Quincy A. , Gbate, Hubert A., Singh, Yashbir , Ghotbi, Elena , Knollmann, Friedrich , Barbosa, Eduardo Mortani, Donuru, Achala , Xu, Dongming, Knollmann, Friedrich D , Singh, Yashbir , Hathaway, Quincy A , Gbate, Hubert, Ghotbi, Elena

Mayo Clinic

Diagnostics | May 28, 2026 | Volume: 16 | Issue: 11 | Pages: 1663

10.3390/diagnostics16111663 | PMID 42279531 Get It

Background/Objectives: Juxtapleural and perifissural nodules are commonly encountered on thoracic imaging, are typically presumed benign, and are often considered to represent intrapulmonary lymph nodes. We evaluated the prevalence, clinical context, and management of juxtapleural nodules over a 10-year period and to assess factors associated with concern for malignancy. Methods: In this retrospective, single-center study, radiology reports from 1 January 2015 to 31 December 2024, were queried using natural language processing to identify examinations containing terminology consistent with juxtapleural nodules. After exclusion of duplicate encounters, 85,435 unique patient encounters were analyzed. Reports were further filtered to identify cases with imaging concern for malignancy and recommendations for follow-up or intervention (N = 659). Clinical characteristics, imaging modality, and prior malignancy history were compared using appropriate statistical tests. Results: Among 85,435 unique encounters, 659 patients (<1%) had juxtapleural nodules considered concerning for malignancy. These patients were older (68 vs. 64 years, p < 0.001), more frequently imaged with PET/CT (8% vs. 5%, p < 0.001), and more likely to be evaluated in inpatient settings (16% vs. 12%, p < 0.001). Of the cohort with a juxtapleural nodule considered concerning for malignancy by imaging criteria, 360 patients (55%) had a prior history of malignancy. In these patients, nodules were more commonly identified in outpatient settings (70% vs. 43%, p < 0.001) and on routine imaging (94% vs. 86%, p < 0.001). Representative cases demonstrated that malignant nodules may mimic benign perifissural morphology on initial imaging. Conclusions: Although the vast majority of reported juxtapleural nodules did not prompt malignancy-directed evaluation, a small subset of cases (approximately 0.8%), particularly in patients with prior malignancy, were interpreted as sufficiently concerning to warrant follow-up imaging or intervention. Because pathologic confirmation and standardized long-term outcome adjudication were not available for all patients, these findings should be interpreted as reflecting real-world radiologist concern and management patterns rather than a definitive malignancy rate.